Jonathan Alspaugh
Chief Accounting Officer
Spyre Therapeutics, Inc. (SYRE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-03-17–present
-
Current
-
Start not stated–2023-09-01
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Spyre Therapeutics, Inc. (SYRE) | Former Chief Financial Officer | $329,767 | $8,360,029 |
| 2022 | Spyre Therapeutics, Inc. (SYRE) | Former Chief Financial Officer | $425,001 | $1,011,840 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.